Global Heart Pump Device Market By Product, By Type, By Therapy, By Region: Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031

  • Industry: Healthcare
  • Report ID: TNR-110-931
  • Number of Pages: 420
  • Table/Charts : Yes
  • November, 2023
  • Base Year : 2024
  • No. of Companies : 10+
  • No. of Countries : 29
  • Views : 10137
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Global Heart Pump Device Market was valued at US$ 2.23 Billion in 2022, growing at an estimated CAGR of 19.1% from 2023-2031.

A heart pump device, also known as a ventricular assist device (VAD), is a mechanical device implanted in the chest or abdomen to support a weakened heart. It helps pump blood throughout the body, assisting individuals with severe heart failure by enhancing circulation and prolonging life while awaiting transplant or as a long-term therapy.

In the global heart pump device market, Ventricular Assist Devices (VADs) segment is currently dominating. VADs were widely used for various heart failure cases, supported by a growing aging population. For instance, the American Heart Association reported that over 6 million Americans were living with heart failure. VADs like the HeartMate 3 by Abbott gained significant traction.

Global Heart Pump Device Market Revenue & Forecast, (US$ Million), 2015 – 2031

Pandemic Impact Analysis on Global Heart Pump Device Market

Pre-COVID-19, the heart pump device market was steadily growing, driven by rising heart disease cases and advancements in cardiac care. However, the pandemic disrupted supply chains and delayed elective procedures, impacting the market’s growth. Post-COVID-19, the market is rebounding as healthcare systems adapt to the new normal, with a renewed focus on addressing heart health issues. The demand for innovative and life-saving heart pump devices remains robust, particularly as the aging population continues to grow and heart-related conditions persist.

Report Coverage and Deliverables

The increasing incidence of heart diseases is a primary driver of the heart pump device market. According to the World Health Organization (WHO), cardiovascular diseases are the leading cause of death globally, accounting for 17.9 million deaths annually. As heart-related ailments continue to rise, there is a growing demand for heart pump devices. This demand is fueled by factors like aging populations, sedentary lifestyles, and dietary habits. For instance, the American Heart Association projected that by 2035, over 130 million adults in the United States would have some form of cardiovascular disease, creating a significant need for advanced heart pump devices. One significant restraint in the market is the high cost of heart pump devices and the budget constraints faced by healthcare systems. The American College of Cardiology reported that the average cost of a Ventricular Assist Device (VAD) implantation procedure in the US exceeded $280,000. These costs can strain healthcare budgets, limiting access to these life-saving devices. Budget constraints and reimbursement challenges in healthcare systems globally can impede the broader adoption of heart pump devices, especially in regions with limited resources. Balancing affordability and advanced cardiac care remains a significant challenge.

Implantable heart pump devices held the dominant position in the market in 2022. These devices are widely used for both short-term and long-term support in patients with heart failure. The market for these devices has witnessed significant growth, driven by increasing heart failure cases and advancements in VAD technology.

North America registered for 46.5% of the global heart pump device market in 2022. This dominance was attributed to the high prevalence of heart diseases and well-established healthcare infrastructure. For instance, the American Heart Association estimated that over 120,000 Ventricular Assist Devices (VADs) had been implanted in the US by 2020, highlighting the market’s strength in the region.

Competitive Landscape

The report presents a combination of qualitative and quantitative research in the global heart pump device market. It provides in-depth insights into the strategies employed by the leading competitors in the industry for development. Moreover, the report offers a comprehensive analysis of key players in this market, assessing their competitive positions. It delves into their business strategies, including activities such as mergers and acquisitions (M&A), partnerships, collaborations, and contracts. The report examines each company’s global footprint, competitors, range of services, and specifications, among other aspects. Some of the key companies operating in the global heart pump device market are

  • Abbott
  • ABIOMED
  • Berlin Heart
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge
  • Jarvik Heart, Inc.
  • LivaNova, Inc.
  • Medtronic
  • SynCardia Systems, LLC
  • Teleflex Incorporated
  • Other Industry Participants

Report Summary of Global Heart Pump Device Market

Report Specifications Details
Market Revenue in 2022 US$ 2.23 Billion
Market Size Forecast by 2031 US$ 9.78 Billion
Growth Rate (CAGR) 19.1%
Historic Data 2015 – 2021
Base Year for Estimation 2022
Forecast Period 2023 – 2031
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By  Product, By Type, By Therapy
Regions Covered North America, Europe, Asia Pacific, Middle East & Africa, Latin America
Countries Covered U.S., Canada, Mexico, Rest of North America,  France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe,  China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific,  Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa,  Brazil, Argentina, Rest of Latin America
Key Players Abbott, ABIOMED, Berlin Heart, Fresenius Medical Care AG & Co. KGaA, Getinge, Jarvik Heart, Inc., LivaNova, Inc., Medtronic, SynCardia Systems, LLC, Teleflex Incorporated, Other Industry Participants
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free): – +81 663-386-8111

South Korea (Toll-Free): – +82-808- 703-126

Saudi Arabia (Toll-Free): – +966 800 850 1643

United States: +1 302-232-5106

United Kingdom: +447537105080

E-mail:  askanexpert@thenicheresearch.com

 

 

Global Heart Pump Device Market:

By Product

  • Ventricular Assist Devices
    • Left Ventricular Assist Devices
    • Percutaneous Ventricular Assist Devices
    • Biventricular Assist Devices
    • Right Ventricular Assist Devices
  • Intra-Aortic Balloon Pumps
  • Total Artificial Hearts

By Type

  • Implantable Heart Pump Devices
  • Extracorporeal Heart Pump Devices

By Therapy

  • Bridge-To-Transplant (BTT)
  • Bridge-To-Candidacy (BTC)
  • Destination Therapy (DT)
  • Other Therapies

By Region

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

.

Table of Contents

.

1.Market Scope
1.1.Market Segmentation

1.2.Years Considered
1.2.1.Historic Years: 2015 – 2021

1.2.2.Base Year: 2022

1.2.3.Forecast Years: 2023 – 2031

2.Key Target Audiences

3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire

3.1.2.Global Percentage Breakdown

3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)

3.2.Secondary Research
3.2.1.Paid Databases

3.2.2.Secondary Sources

3.3.Market Size Estimates
3.3.1.Top-Down Approach

3.3.2.Bottom-Up Approach

3.4.Data Triangulation Methodology

3.5.Research Assumptions

4.Recommendations and Insights from TNR’s Perspective**

5.Holistic Overview of Heart Pump Device Market

6.Market Synopsis: Heart Pump Device Market

7.Heart Pump Device Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition

7.1.2.Industry Development

7.2.Market Dynamics
7.2.1.Drivers

7.2.2.Restraints

7.2.3.Opportunities

7.2.4.Challenges

7.3.Trends in Heart Pump Device Market

7.4.Market Determinants Radar Chart

7.5.Macro-Economic and Micro-Economic Indicators: Heart Pump Device Market

7.6.Impact of Covid-19 on Heart Pump Device Market

8.Global Heart Pump Device Market Analysis and Forecasts, 2023 – 2031
8.1.Overview
8.1.1.Global Heart Pump Device Market Revenue (US$ Mn)

8.2.Global Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
8.2.1.Ventricular Assist Devices (Definition, Market Estimation and Penetration, 2015 – 2022, Market Estimation (2015 – 2022), Market Forecast (2023 – 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin America) and Information on Left Ventricular Assist Devices  , Percutaneous Ventricular Assist Devices, Biventricular Assist Devices, Right Ventricular Assist Devices)
8.2.1.1.Left Ventricular Assist Devices  

8.2.1.2.Percutaneous Ventricular Assist Devices

8.2.1.3.Biventricular Assist Devices

8.2.1.4.Right Ventricular Assist Devices

8.2.2.Intra-Aortic Balloon Pumps
8.2.2.1.Definition

8.2.2.2.Market Estimation and Penetration, 2015 – 2022

8.2.2.3.Market Forecast, 2023 – 2031

8.2.2.4.Compound Annual Growth Rate (CAGR)

8.2.2.5.Regional Bifurcation
8.2.2.5.1.North America
8.2.2.5.1.1.Market Estimation, 2015 – 2022

8.2.2.5.1.2.Market Forecast, 2023 – 2031

8.2.2.5.2.Europe
8.2.2.5.2.1.Market Estimation, 2015 – 2022

8.2.2.5.2.2.Market Forecast, 2023 – 2031

8.2.2.5.3.Asia Pacific
8.2.2.5.3.1.Market Estimation, 2015 – 2022

8.2.2.5.3.2.Market Forecast, 2023 – 2031

8.2.2.5.4.Middle East and Africa
8.2.2.5.4.1.Market Estimation, 2015 – 2022

8.2.2.5.4.2.Market Forecast, 2023 – 2031

8.2.2.5.5.Latin America
8.2.2.5.5.1.Market Estimation, 2015 – 2022

8.2.2.5.5.2.Market Forecast, 2023 – 2031

8.2.3.Total Artificial Hearts
8.2.3.1.Definition

8.2.3.2.Market Estimation and Penetration, 2015 – 2022

8.2.3.3.Market Forecast, 2023 – 2031

8.2.3.4.Compound Annual Growth Rate (CAGR)

8.2.3.5.Regional Bifurcation
8.2.3.5.1.North America
8.2.3.5.1.1.Market Estimation, 2015 – 2022

8.2.3.5.1.2.Market Forecast, 2023 – 2031

8.2.3.5.2.Europe
8.2.3.5.2.1.Market Estimation, 2015 – 2022

8.2.3.5.2.2.Market Forecast, 2023 – 2031

8.2.3.5.3.Asia Pacific
8.2.3.5.3.1.Market Estimation, 2015 – 2022

8.2.3.5.3.2.Market Forecast, 2023 – 2031

8.2.3.5.4.Middle East and Africa
8.2.3.5.4.1.Market Estimation, 2015 – 2022

8.2.3.5.4.2.Market Forecast, 2023 – 2031

8.2.3.5.5.Latin America
8.2.3.5.5.1.Market Estimation, 2015 – 2022

8.2.3.5.5.2.Market Forecast, 2023 – 2031

8.3.Key Segment for Channeling Investments
8.3.1.By Product

9.Global Heart Pump Device Market Analysis and Forecasts, 2023 – 2031
9.1.Overview

9.2.Global Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
9.2.1.Implantable Heart Pump Devices
9.2.1.1.Definition

9.2.1.2.Market Estimation and Penetration, 2015 – 2022

9.2.1.3.Market Forecast, 2023 – 2031

9.2.1.4.Compound Annual Growth Rate (CAGR)

9.2.1.5.Regional Bifurcation
9.2.1.5.1.North America
9.2.1.5.1.1.Market Estimation, 2015 – 2022

9.2.1.5.1.2.Market Forecast, 2023 – 2031

9.2.1.5.2.Europe
9.2.1.5.2.1.Market Estimation, 2015 – 2022

9.2.1.5.2.2.Market Forecast, 2023 – 2031

9.2.1.5.3.Asia Pacific
9.2.1.5.3.1.Market Estimation, 2015 – 2022

9.2.1.5.3.2.Market Forecast, 2023 – 2031

9.2.1.5.4.Middle East and Africa
9.2.1.5.4.1.Market Estimation, 2015 – 2022

9.2.1.5.4.2.Market Forecast, 2023 – 2031

9.2.1.5.5.Latin America
9.2.1.5.5.1.Market Estimation, 2015 – 2022

9.2.1.5.5.2.Market Forecast, 2023 – 2031

9.2.2.Extracorporeal Heart Pump Devices
9.2.2.1.Definition

9.2.2.2.Market Estimation and Penetration, 2015 – 2022

9.2.2.3.Market Forecast, 2023 – 2031

9.2.2.4.Compound Annual Growth Rate (CAGR)

9.2.2.5.Regional Bifurcation
9.2.2.5.1.North America
9.2.2.5.1.1.Market Estimation, 2015 – 2022

9.2.2.5.1.2.Market Forecast, 2023 – 2031

9.2.2.5.2.Europe
9.2.2.5.2.1.Market Estimation, 2015 – 2022

9.2.2.5.2.2.Market Forecast, 2023 – 2031

9.2.2.5.3.Asia Pacific
9.2.2.5.3.1.Market Estimation, 2015 – 2022

9.2.2.5.3.2.Market Forecast, 2023 – 2031

9.2.2.5.4.Middle East and Africa
9.2.2.5.4.1.Market Estimation, 2015 – 2022

9.2.2.5.4.2.Market Forecast, 2023 – 2031

9.2.2.5.5.Latin America
9.2.2.5.5.1.Market Estimation, 2015 – 2022

9.2.2.5.5.2.Market Forecast, 2023 – 2031

9.3.Key Segment for Channeling Investments
9.3.1.By Type

10.Global Heart Pump Device Market Analysis and Forecasts, 2023 – 2031
10.1.Overview

10.2.Global Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
10.2.1.Bridge-To-Transplant (BTT)
10.2.1.1.Definition

10.2.1.2.Market Estimation and Penetration, 2015 – 2022

10.2.1.3.Market Forecast, 2023 – 2031

10.2.1.4.Compound Annual Growth Rate (CAGR)

10.2.1.5.Regional Bifurcation
10.2.1.5.1.North America
10.2.1.5.1.1.Market Estimation, 2015 – 2022

10.2.1.5.1.2.Market Forecast, 2023 – 2031

10.2.1.5.2.Europe
10.2.1.5.2.1.Market Estimation, 2015 – 2022

10.2.1.5.2.2.Market Forecast, 2023 – 2031

10.2.1.5.3.Asia Pacific
10.2.1.5.3.1.Market Estimation, 2015 – 2022

10.2.1.5.3.2.Market Forecast, 2023 – 2031

10.2.1.5.4.Middle East and Africa
10.2.1.5.4.1.Market Estimation, 2015 – 2022

10.2.1.5.4.2.Market Forecast, 2023 – 2031

10.2.1.5.5.Latin America
10.2.1.5.5.1.Market Estimation, 2015 – 2022

10.2.1.5.5.2.Market Forecast, 2023 – 2031

10.2.2.Bridge-To-Candidacy (BTC)
10.2.2.1.Definition

10.2.2.2.Market Estimation and Penetration, 2015 – 2022

10.2.2.3.Market Forecast, 2023 – 2031

10.2.2.4.Compound Annual Growth Rate (CAGR)

10.2.2.5.Regional Bifurcation
10.2.2.5.1.North America
10.2.2.5.1.1.Market Estimation, 2015 – 2022

10.2.2.5.1.2.Market Forecast, 2023 – 2031

10.2.2.5.2.Europe
10.2.2.5.2.1.Market Estimation, 2015 – 2022

10.2.2.5.2.2.Market Forecast, 2023 – 2031

10.2.2.5.3.Asia Pacific
10.2.2.5.3.1.Market Estimation, 2015 – 2022

10.2.2.5.3.2.Market Forecast, 2023 – 2031

10.2.2.5.4.Middle East and Africa
10.2.2.5.4.1.Market Estimation, 2015 – 2022

10.2.2.5.4.2.Market Forecast, 2023 – 2031

10.2.2.5.5.Latin America
10.2.2.5.5.1.Market Estimation, 2015 – 2022

10.2.2.5.5.2.Market Forecast, 2023 – 2031

10.2.3.Destination Therapy (DT)
10.2.3.1.Definition

10.2.3.2.Market Estimation and Penetration, 2015 – 2022

10.2.3.3.Market Forecast, 2023 – 2031

10.2.3.4.Compound Annual Growth Rate (CAGR)

10.2.3.5.Regional Bifurcation
10.2.3.5.1.North America
10.2.3.5.1.1.Market Estimation, 2015 – 2022

10.2.3.5.1.2.Market Forecast, 2023 – 2031

10.2.3.5.2.Europe
10.2.3.5.2.1.Market Estimation, 2015 – 2022

10.2.3.5.2.2.Market Forecast, 2023 – 2031

10.2.3.5.3.Asia Pacific
10.2.3.5.3.1.Market Estimation, 2015 – 2022

10.2.3.5.3.2.Market Forecast, 2023 – 2031

10.2.3.5.4.Middle East and Africa
10.2.3.5.4.1.Market Estimation, 2015 – 2022

10.2.3.5.4.2.Market Forecast, 2023 – 2031

10.2.3.5.5.Latin America
10.2.3.5.5.1.Market Estimation, 2015 – 2022

10.2.3.5.5.2.Market Forecast, 2023 – 2031

10.2.4.Other Therapies
10.2.4.1.Definition

10.2.4.2.Market Estimation and Penetration, 2015 – 2022

10.2.4.3.Market Forecast, 2023 – 2031

10.2.4.4.Compound Annual Growth Rate (CAGR)

10.2.4.5.Regional Bifurcation
10.2.4.5.1.North America
10.2.4.5.1.1.Market Estimation, 2015 – 2022

10.2.4.5.1.2.Market Forecast, 2023 – 2031

10.2.4.5.2.Europe
10.2.4.5.2.1.Market Estimation, 2015 – 2022

10.2.4.5.2.2.Market Forecast, 2023 – 2031

10.2.4.5.3.Asia Pacific
10.2.4.5.3.1.Market Estimation, 2015 – 2022

10.2.4.5.3.2.Market Forecast, 2023 – 2031

10.2.4.5.4.Middle East and Africa
10.2.4.5.4.1.Market Estimation, 2015 – 2022

10.2.4.5.4.2.Market Forecast, 2023 – 2031

10.2.4.5.5.Latin America
10.2.4.5.5.1.Market Estimation, 2015 – 2022

10.2.4.5.5.2.Market Forecast, 2023 – 2031

10.3.Key Segment for Channeling Investments
10.3.1.By Therapy

11.North America Heart Pump Device Market Analysis and Forecasts, 2023 – 2031
11.1.Overview
11.1.1.North America Heart Pump Device Market Revenue (US$ Mn)

11.2.North America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
11.2.1.Ventricular Assist Devices
11.2.1.1.Left Ventricular Assist Devices  

11.2.1.2.Percutaneous Ventricular Assist Devices

11.2.1.3.Biventricular Assist Devices

11.2.1.4.Right Ventricular Assist Devices

11.2.2.Intra-Aortic Balloon Pumps

11.2.3.Total Artificial Hearts

11.3.North America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
11.3.1.Implantable Heart Pump Devices

11.3.2.Extracorporeal Heart Pump Devices

11.4.North America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
11.4.1.Bridge-To-Transplant (BTT)

11.4.2.Bridge-To-Candidacy (BTC)

11.4.3.Destination Therapy (DT)

11.4.4.Other Therapies

11.5.North America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Country
11.5.1.U.S
11.5.1.1.U.S Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
11.5.1.1.1.Ventricular Assist Devices
11.5.1.1.1.1.Left Ventricular Assist Devices  

11.5.1.1.1.2.Percutaneous Ventricular Assist Devices

11.5.1.1.1.3.Biventricular Assist Devices

11.5.1.1.1.4.Right Ventricular Assist Devices

11.5.1.1.2.Intra-Aortic Balloon Pumps

11.5.1.1.3.Total Artificial Hearts

11.5.1.2.U.S Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
11.5.1.2.1.Implantable Heart Pump Devices

11.5.1.2.2.Extracorporeal Heart Pump Devices

11.5.1.3.U.S Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
11.5.1.3.1.Bridge-To-Transplant (BTT)

11.5.1.3.2.Bridge-To-Candidacy (BTC)

11.5.1.3.3.Destination Therapy (DT)

11.5.1.3.4.Other Therapies

11.5.2.Canada
11.5.2.1.Canada Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
11.5.2.1.1.Ventricular Assist Devices
11.5.2.1.1.1.Left Ventricular Assist Devices  

11.5.2.1.1.2.Percutaneous Ventricular Assist Devices

11.5.2.1.1.3.Biventricular Assist Devices

11.5.2.1.1.4.Right Ventricular Assist Devices

11.5.2.1.2.Intra-Aortic Balloon Pumps

11.5.2.1.3.Total Artificial Hearts

11.5.2.2.Canada Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
11.5.2.2.1.Implantable Heart Pump Devices

11.5.2.2.2.Extracorporeal Heart Pump Devices

11.5.2.3.Canada Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
11.5.2.3.1.Bridge-To-Transplant (BTT)

11.5.2.3.2.Bridge-To-Candidacy (BTC)

11.5.2.3.3.Destination Therapy (DT)

11.5.2.3.4.Other Therapies

11.5.3.Mexico
11.5.3.1.Mexico Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
11.5.3.1.1.Ventricular Assist Devices
11.5.3.1.1.1.Left Ventricular Assist Devices  

11.5.3.1.1.2.Percutaneous Ventricular Assist Devices

11.5.3.1.1.3.Biventricular Assist Devices

11.5.3.1.1.4.Right Ventricular Assist Devices

11.5.3.1.2.Intra-Aortic Balloon Pumps

11.5.3.1.3.Total Artificial Hearts

11.5.3.2.Mexico Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
11.5.3.2.1.Implantable Heart Pump Devices

11.5.3.2.2.Extracorporeal Heart Pump Devices

11.5.3.3.Mexico Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
11.5.3.3.1.Bridge-To-Transplant (BTT)

11.5.3.3.2.Bridge-To-Candidacy (BTC)

11.5.3.3.3.Destination Therapy (DT)

11.5.3.3.4.Other Therapies

11.5.4.Rest of North America
11.5.4.1.Rest of North America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
11.5.4.1.1.Ventricular Assist Devices
11.5.4.1.1.1.Left Ventricular Assist Devices  

11.5.4.1.1.2.Percutaneous Ventricular Assist Devices

11.5.4.1.1.3.Biventricular Assist Devices

11.5.4.1.1.4.Right Ventricular Assist Devices

11.5.4.1.2.Intra-Aortic Balloon Pumps

11.5.4.1.3.Total Artificial Hearts

11.5.4.2.Rest of North America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
11.5.4.2.1.Implantable Heart Pump Devices

11.5.4.2.2.Extracorporeal Heart Pump Devices

11.5.4.3.Rest of North America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
11.5.4.3.1.Bridge-To-Transplant (BTT)

11.5.4.3.2.Bridge-To-Candidacy (BTC)

11.5.4.3.3.Destination Therapy (DT)

11.5.4.3.4.Other Therapies

11.6.Key Segment for Channeling Investments
11.6.1.By Country

11.6.2.By Product

11.6.3.By Type

11.6.4.By Therapy

12.Europe Heart Pump Device Market Analysis and Forecasts, 2023 – 2031
12.1.Overview
12.1.1.Europe Heart Pump Device Market Revenue (US$ Mn)

12.2.Europe Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.2.1.Ventricular Assist Devices
12.2.1.1.Left Ventricular Assist Devices  

12.2.1.2.Percutaneous Ventricular Assist Devices

12.2.1.3.Biventricular Assist Devices

12.2.1.4.Right Ventricular Assist Devices

12.2.2.Intra-Aortic Balloon Pumps

12.2.3.Total Artificial Hearts

12.3.Europe Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.3.1.Implantable Heart Pump Devices

12.3.2.Extracorporeal Heart Pump Devices

12.4.Europe Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.4.1.Bridge-To-Transplant (BTT)

12.4.2.Bridge-To-Candidacy (BTC)

12.4.3.Destination Therapy (DT)

12.4.4.Other Therapies

12.5.Europe Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1.France
12.5.1.1.France Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.5.1.1.1.Ventricular Assist Devices
12.5.1.1.1.1.Left Ventricular Assist Devices  

12.5.1.1.1.2.Percutaneous Ventricular Assist Devices

12.5.1.1.1.3.Biventricular Assist Devices

12.5.1.1.1.4.Right Ventricular Assist Devices

12.5.1.1.2.Intra-Aortic Balloon Pumps

12.5.1.1.3.Total Artificial Hearts

12.5.1.2.France Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.5.1.2.1.Implantable Heart Pump Devices

12.5.1.2.2.Extracorporeal Heart Pump Devices

12.5.1.3.France Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.5.1.3.1.Bridge-To-Transplant (BTT)

12.5.1.3.2.Bridge-To-Candidacy (BTC)

12.5.1.3.3.Destination Therapy (DT)

12.5.1.3.4.Other Therapies

12.5.2.The UK
12.5.2.1.The UK Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.5.2.1.1.Ventricular Assist Devices
12.5.2.1.1.1.Left Ventricular Assist Devices  

12.5.2.1.1.2.Percutaneous Ventricular Assist Devices

12.5.2.1.1.3.Biventricular Assist Devices

12.5.2.1.1.4.Right Ventricular Assist Devices

12.5.2.1.2.Intra-Aortic Balloon Pumps

12.5.2.1.3.Total Artificial Hearts

12.5.2.2.The UK Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.5.2.2.1.Implantable Heart Pump Devices

12.5.2.2.2.Extracorporeal Heart Pump Devices

12.5.2.3.The UK Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.5.2.3.1.Bridge-To-Transplant (BTT)

12.5.2.3.2.Bridge-To-Candidacy (BTC)

12.5.2.3.3.Destination Therapy (DT)

12.5.2.3.4.Other Therapies

12.5.3.Spain
12.5.3.1.Spain Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.5.3.1.1.Ventricular Assist Devices
12.5.3.1.1.1.Left Ventricular Assist Devices  

12.5.3.1.1.2.Percutaneous Ventricular Assist Devices

12.5.3.1.1.3.Biventricular Assist Devices

12.5.3.1.1.4.Right Ventricular Assist Devices

12.5.3.1.2.Intra-Aortic Balloon Pumps

12.5.3.1.3.Total Artificial Hearts

12.5.3.2.Spain Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.5.3.2.1.Implantable Heart Pump Devices

12.5.3.2.2.Extracorporeal Heart Pump Devices

12.5.3.3.Spain Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.5.3.3.1.Bridge-To-Transplant (BTT)

12.5.3.3.2.Bridge-To-Candidacy (BTC)

12.5.3.3.3.Destination Therapy (DT)

12.5.3.3.4.Other Therapies

12.5.4.Germany
12.5.4.1.Germany Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.5.4.1.1.Ventricular Assist Devices
12.5.4.1.1.1.Left Ventricular Assist Devices  

12.5.4.1.1.2.Percutaneous Ventricular Assist Devices

12.5.4.1.1.3.Biventricular Assist Devices

12.5.4.1.1.4.Right Ventricular Assist Devices

12.5.4.1.2.Intra-Aortic Balloon Pumps

12.5.4.1.3.Total Artificial Hearts

12.5.4.2.Germany Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.5.4.2.1.Implantable Heart Pump Devices

12.5.4.2.2.Extracorporeal Heart Pump Devices

12.5.4.3.Germany Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.5.4.3.1.Bridge-To-Transplant (BTT)

12.5.4.3.2.Bridge-To-Candidacy (BTC)

12.5.4.3.3.Destination Therapy (DT)

12.5.4.3.4.Other Therapies

12.5.5.Italy
12.5.5.1.Italy Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.5.5.1.1.Ventricular Assist Devices
12.5.5.1.1.1.Left Ventricular Assist Devices  

12.5.5.1.1.2.Percutaneous Ventricular Assist Devices

12.5.5.1.1.3.Biventricular Assist Devices

12.5.5.1.1.4.Right Ventricular Assist Devices

12.5.5.1.2.Intra-Aortic Balloon Pumps

12.5.5.1.3.Total Artificial Hearts

12.5.5.2.Italy Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.5.5.2.1.Implantable Heart Pump Devices

12.5.5.2.2.Extracorporeal Heart Pump Devices

12.5.5.3.Italy Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.5.5.3.1.Bridge-To-Transplant (BTT)

12.5.5.3.2.Bridge-To-Candidacy (BTC)

12.5.5.3.3.Destination Therapy (DT)

12.5.5.3.4.Other Therapies

12.5.6.Nordic Countries
12.5.6.1.Nordic Countries Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.5.6.1.1.Ventricular Assist Devices
12.5.6.1.1.1.Left Ventricular Assist Devices  

12.5.6.1.1.2.Percutaneous Ventricular Assist Devices

12.5.6.1.1.3.Biventricular Assist Devices

12.5.6.1.1.4.Right Ventricular Assist Devices

12.5.6.1.2.Intra-Aortic Balloon Pumps

12.5.6.1.3.Total Artificial Hearts

12.5.6.2.Nordic Countries Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.5.6.2.1.Implantable Heart Pump Devices

12.5.6.2.2.Extracorporeal Heart Pump Devices

12.5.6.3.Nordic Countries Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.5.6.3.1.Bridge-To-Transplant (BTT)

12.5.6.3.2.Bridge-To-Candidacy (BTC)

12.5.6.3.3.Destination Therapy (DT)

12.5.6.3.4.Other Therapies

12.5.6.4.Nordic Countries Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Country
12.5.6.4.1.Denmark

12.5.6.4.2.Finland

12.5.6.4.3.Iceland

12.5.6.4.4.Sweden

12.5.6.4.5.Norway

12.5.7.Benelux Union
12.5.7.1.Benelux Union Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.5.7.1.1.Ventricular Assist Devices
12.5.7.1.1.1.Left Ventricular Assist Devices  

12.5.7.1.1.2.Percutaneous Ventricular Assist Devices

12.5.7.1.1.3.Biventricular Assist Devices

12.5.7.1.1.4.Right Ventricular Assist Devices

12.5.7.1.2.Intra-Aortic Balloon Pumps

12.5.7.1.3.Total Artificial Hearts

12.5.7.2.Benelux Union Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.5.7.2.1.Implantable Heart Pump Devices

12.5.7.2.2.Extracorporeal Heart Pump Devices

12.5.7.3.Benelux Union Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.5.7.3.1.Bridge-To-Transplant (BTT)

12.5.7.3.2.Bridge-To-Candidacy (BTC)

12.5.7.3.3.Destination Therapy (DT)

12.5.7.3.4.Other Therapies

12.5.7.4.Benelux Union Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Country
12.5.7.4.1.Belgium

12.5.7.4.2.The Netherlands

12.5.7.4.3.Luxembourg

12.5.8.Rest of Europe
12.5.8.1.Rest of Europe Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
12.5.8.1.1.Ventricular Assist Devices
12.5.8.1.1.1.Left Ventricular Assist Devices  

12.5.8.1.1.2.Percutaneous Ventricular Assist Devices

12.5.8.1.1.3.Biventricular Assist Devices

12.5.8.1.1.4.Right Ventricular Assist Devices

12.5.8.1.2.Intra-Aortic Balloon Pumps

12.5.8.1.3.Total Artificial Hearts

12.5.8.2.Rest of Europe Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
12.5.8.2.1.Implantable Heart Pump Devices

12.5.8.2.2.Extracorporeal Heart Pump Devices

12.5.8.3.Rest of Europe Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
12.5.8.3.1.Bridge-To-Transplant (BTT)

12.5.8.3.2.Bridge-To-Candidacy (BTC)

12.5.8.3.3.Destination Therapy (DT)

12.5.8.3.4.Other Therapies

12.6.Key Segment for Channeling Investments
12.6.1.By Country

12.6.2.By Product

12.6.3.By Type

12.6.4.By Therapy

13.Asia Pacific Heart Pump Device Market Analysis and Forecasts, 2023 – 2031
13.1.Overview
13.1.1.Asia Pacific Heart Pump Device Market Revenue (US$ Mn)

13.2.Asia Pacific Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.2.1.Ventricular Assist Devices
13.2.1.1.Left Ventricular Assist Devices  

13.2.1.2.Percutaneous Ventricular Assist Devices

13.2.1.3.Biventricular Assist Devices

13.2.1.4.Right Ventricular Assist Devices

13.2.2.Intra-Aortic Balloon Pumps

13.2.3.Total Artificial Hearts

13.3.Asia Pacific Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.3.1.Implantable Heart Pump Devices

13.3.2.Extracorporeal Heart Pump Devices

13.4.Asia Pacific Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.4.1.Bridge-To-Transplant (BTT)

13.4.2.Bridge-To-Candidacy (BTC)

13.4.3.Destination Therapy (DT)

13.4.4.Other Therapies

13.5.Asia Pacific Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Country
13.5.1.China
13.5.1.1.China Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.5.1.1.1.Ventricular Assist Devices
13.5.1.1.1.1.Left Ventricular Assist Devices  

13.5.1.1.1.2.Percutaneous Ventricular Assist Devices

13.5.1.1.1.3.Biventricular Assist Devices

13.5.1.1.1.4.Right Ventricular Assist Devices

13.5.1.1.2.Intra-Aortic Balloon Pumps

13.5.1.1.3.Total Artificial Hearts

13.5.1.2.China Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.5.1.2.1.Implantable Heart Pump Devices

13.5.1.2.2.Extracorporeal Heart Pump Devices

13.5.1.3.China Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.5.1.3.1.Bridge-To-Transplant (BTT)

13.5.1.3.2.Bridge-To-Candidacy (BTC)

13.5.1.3.3.Destination Therapy (DT)

13.5.1.3.4.Other Therapies

13.5.2.Japan
13.5.2.1.Japan Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.5.2.1.1.Ventricular Assist Devices
13.5.2.1.1.1.Left Ventricular Assist Devices  

13.5.2.1.1.2.Percutaneous Ventricular Assist Devices

13.5.2.1.1.3.Biventricular Assist Devices

13.5.2.1.1.4.Right Ventricular Assist Devices

13.5.2.1.2.Intra-Aortic Balloon Pumps

13.5.2.1.3.Total Artificial Hearts

13.5.2.2.Japan Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.5.2.2.1.Implantable Heart Pump Devices

13.5.2.2.2.Extracorporeal Heart Pump Devices

13.5.2.3.Japan Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.5.2.3.1.Bridge-To-Transplant (BTT)

13.5.2.3.2.Bridge-To-Candidacy (BTC)

13.5.2.3.3.Destination Therapy (DT)

13.5.2.3.4.Other Therapies

13.5.3.India
13.5.3.1.India Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.5.3.1.1.Ventricular Assist Devices
13.5.3.1.1.1.Left Ventricular Assist Devices  

13.5.3.1.1.2.Percutaneous Ventricular Assist Devices

13.5.3.1.1.3.Biventricular Assist Devices

13.5.3.1.1.4.Right Ventricular Assist Devices

13.5.3.1.2.Intra-Aortic Balloon Pumps

13.5.3.1.3.Total Artificial Hearts

13.5.3.2.India Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.5.3.2.1.Implantable Heart Pump Devices

13.5.3.2.2.Extracorporeal Heart Pump Devices

13.5.3.3.India Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.5.3.3.1.Bridge-To-Transplant (BTT)

13.5.3.3.2.Bridge-To-Candidacy (BTC)

13.5.3.3.3.Destination Therapy (DT)

13.5.3.3.4.Other Therapies

13.5.4.New Zealand
13.5.4.1.New Zealand Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.5.4.1.1.Ventricular Assist Devices
13.5.4.1.1.1.Left Ventricular Assist Devices  

13.5.4.1.1.2.Percutaneous Ventricular Assist Devices

13.5.4.1.1.3.Biventricular Assist Devices

13.5.4.1.1.4.Right Ventricular Assist Devices

13.5.4.1.2.Intra-Aortic Balloon Pumps

13.5.4.1.3.Total Artificial Hearts

13.5.4.2.New Zealand Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.5.4.2.1.Implantable Heart Pump Devices

13.5.4.2.2.Extracorporeal Heart Pump Devices

13.5.4.3.New Zealand Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.5.4.3.1.Bridge-To-Transplant (BTT)

13.5.4.3.2.Bridge-To-Candidacy (BTC)

13.5.4.3.3.Destination Therapy (DT)

13.5.4.3.4.Other Therapies

13.5.5.Australia
13.5.5.1.Australia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.5.5.1.1.Ventricular Assist Devices
13.5.5.1.1.1.Left Ventricular Assist Devices  

13.5.5.1.1.2.Percutaneous Ventricular Assist Devices

13.5.5.1.1.3.Biventricular Assist Devices

13.5.5.1.1.4.Right Ventricular Assist Devices

13.5.5.1.2.Intra-Aortic Balloon Pumps

13.5.5.1.3.Total Artificial Hearts

13.5.5.2.Australia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.5.5.2.1.Implantable Heart Pump Devices

13.5.5.2.2.Extracorporeal Heart Pump Devices

13.5.5.3.Australia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.5.5.3.1.Bridge-To-Transplant (BTT)

13.5.5.3.2.Bridge-To-Candidacy (BTC)

13.5.5.3.3.Destination Therapy (DT)

13.5.5.3.4.Other Therapies

13.5.6.South Korea
13.5.6.1.South Korea Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.5.6.1.1.Ventricular Assist Devices
13.5.6.1.1.1.Left Ventricular Assist Devices  

13.5.6.1.1.2.Percutaneous Ventricular Assist Devices

13.5.6.1.1.3.Biventricular Assist Devices

13.5.6.1.1.4.Right Ventricular Assist Devices

13.5.6.1.2.Intra-Aortic Balloon Pumps

13.5.6.1.3.Total Artificial Hearts

13.5.6.2.South Korea Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.5.6.2.1.Implantable Heart Pump Devices

13.5.6.2.2.Extracorporeal Heart Pump Devices

13.5.6.3.South Korea Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.5.6.3.1.Bridge-To-Transplant (BTT)

13.5.6.3.2.Bridge-To-Candidacy (BTC)

13.5.6.3.3.Destination Therapy (DT)

13.5.6.3.4.Other Therapies

13.5.7.Southeast Asia
13.5.7.1.Southeast Asia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.5.7.1.1.Ventricular Assist Devices
13.5.7.1.1.1.Left Ventricular Assist Devices  

13.5.7.1.1.2.Percutaneous Ventricular Assist Devices

13.5.7.1.1.3.Biventricular Assist Devices

13.5.7.1.1.4.Right Ventricular Assist Devices

13.5.7.1.2.Intra-Aortic Balloon Pumps

13.5.7.1.3.Total Artificial Hearts

13.5.7.2.Southeast Asia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.5.7.2.1.Implantable Heart Pump Devices

13.5.7.2.2.Extracorporeal Heart Pump Devices

13.5.7.3.Southeast Asia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.5.7.3.1.Bridge-To-Transplant (BTT)

13.5.7.3.2.Bridge-To-Candidacy (BTC)

13.5.7.3.3.Destination Therapy (DT)

13.5.7.3.4.Other Therapies

13.5.7.4.Southeast Asia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Country
13.5.7.4.1.Indonesia

13.5.7.4.2.Thailand

13.5.7.4.3.Malaysia

13.5.7.4.4.Singapore

13.5.7.4.5.Rest of Southeast Asia

13.5.8.Rest of Asia Pacific
13.5.8.1.Rest of Asia Pacific Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
13.5.8.1.1.Ventricular Assist Devices
13.5.8.1.1.1.Left Ventricular Assist Devices  

13.5.8.1.1.2.Percutaneous Ventricular Assist Devices

13.5.8.1.1.3.Biventricular Assist Devices

13.5.8.1.1.4.Right Ventricular Assist Devices

13.5.8.1.2.Intra-Aortic Balloon Pumps

13.5.8.1.3.Total Artificial Hearts

13.5.8.2.Rest of Asia Pacific Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
13.5.8.2.1.Implantable Heart Pump Devices

13.5.8.2.2.Extracorporeal Heart Pump Devices

13.5.8.3.Rest of Asia Pacific Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
13.5.8.3.1.Bridge-To-Transplant (BTT)

13.5.8.3.2.Bridge-To-Candidacy (BTC)

13.5.8.3.3.Destination Therapy (DT)

13.5.8.3.4.Other Therapies

13.6.Key Segment for Channeling Investments
13.6.1.By Country

13.6.2.By Product

13.6.3.By Type

13.6.4.By Therapy

14.Middle East and Africa Heart Pump Device Market Analysis and Forecasts, 2023 – 2031
14.1.Overview
14.1.1.Middle East and Africa Heart Pump Device Market Revenue (US$ Mn)

14.2.Middle East and Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
14.2.1.Ventricular Assist Devices
14.2.1.1.Left Ventricular Assist Devices  

14.2.1.2.Percutaneous Ventricular Assist Devices

14.2.1.3.Biventricular Assist Devices

14.2.1.4.Right Ventricular Assist Devices

14.2.2.Intra-Aortic Balloon Pumps

14.2.3.Total Artificial Hearts

14.3.Middle East and Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
14.3.1.Implantable Heart Pump Devices

14.3.2.Extracorporeal Heart Pump Devices

14.4.Middle East and Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
14.4.1.Bridge-To-Transplant (BTT)

14.4.2.Bridge-To-Candidacy (BTC)

14.4.3.Destination Therapy (DT)

14.4.4.Other Therapies

14.5.Middle East and Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Country
14.5.1.Saudi Arabia
14.5.1.1.Saudi Arabia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
14.5.1.1.1.Ventricular Assist Devices
14.5.1.1.1.1.Left Ventricular Assist Devices  

14.5.1.1.1.2.Percutaneous Ventricular Assist Devices

14.5.1.1.1.3.Biventricular Assist Devices

14.5.1.1.1.4.Right Ventricular Assist Devices

14.5.1.1.2.Intra-Aortic Balloon Pumps

14.5.1.1.3.Total Artificial Hearts

14.5.1.2.Saudi Arabia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
14.5.1.2.1.Implantable Heart Pump Devices

14.5.1.2.2.Extracorporeal Heart Pump Devices

14.5.1.3.Saudi Arabia Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
14.5.1.3.1.Bridge-To-Transplant (BTT)

14.5.1.3.2.Bridge-To-Candidacy (BTC)

14.5.1.3.3.Destination Therapy (DT)

14.5.1.3.4.Other Therapies

14.5.2.UAE
14.5.2.1.UAE Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
14.5.2.1.1.Ventricular Assist Devices
14.5.2.1.1.1.Left Ventricular Assist Devices  

14.5.2.1.1.2.Percutaneous Ventricular Assist Devices

14.5.2.1.1.3.Biventricular Assist Devices

14.5.2.1.1.4.Right Ventricular Assist Devices

14.5.2.1.2.Intra-Aortic Balloon Pumps

14.5.2.1.3.Total Artificial Hearts

14.5.2.2.UAE Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
14.5.2.2.1.Implantable Heart Pump Devices

14.5.2.2.2.Extracorporeal Heart Pump Devices

14.5.2.3.UAE Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
14.5.2.3.1.Bridge-To-Transplant (BTT)

14.5.2.3.2.Bridge-To-Candidacy (BTC)

14.5.2.3.3.Destination Therapy (DT)

14.5.2.3.4.Other Therapies

14.5.3.Egypt
14.5.3.1.Egypt Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
14.5.3.1.1.Ventricular Assist Devices
14.5.3.1.1.1.Left Ventricular Assist Devices  

14.5.3.1.1.2.Percutaneous Ventricular Assist Devices

14.5.3.1.1.3.Biventricular Assist Devices

14.5.3.1.1.4.Right Ventricular Assist Devices

14.5.3.1.2.Intra-Aortic Balloon Pumps

14.5.3.1.3.Total Artificial Hearts

14.5.3.2.Egypt Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
14.5.3.2.1.Implantable Heart Pump Devices

14.5.3.2.2.Extracorporeal Heart Pump Devices

14.5.3.3.Egypt Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
14.5.3.3.1.Bridge-To-Transplant (BTT)

14.5.3.3.2.Bridge-To-Candidacy (BTC)

14.5.3.3.3.Destination Therapy (DT)

14.5.3.3.4.Other Therapies

14.5.4.Kuwait
14.5.4.1.Kuwait Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
14.5.4.1.1.Ventricular Assist Devices
14.5.4.1.1.1.Left Ventricular Assist Devices  

14.5.4.1.1.2.Percutaneous Ventricular Assist Devices

14.5.4.1.1.3.Biventricular Assist Devices

14.5.4.1.1.4.Right Ventricular Assist Devices

14.5.4.1.2.Intra-Aortic Balloon Pumps

14.5.4.1.3.Total Artificial Hearts

14.5.4.2.Kuwait Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
14.5.4.2.1.Implantable Heart Pump Devices

14.5.4.2.2.Extracorporeal Heart Pump Devices

14.5.4.3.Kuwait Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
14.5.4.3.1.Bridge-To-Transplant (BTT)

14.5.4.3.2.Bridge-To-Candidacy (BTC)

14.5.4.3.3.Destination Therapy (DT)

14.5.4.3.4.Other Therapies

14.5.5.South Africa
14.5.5.1.South Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
14.5.5.1.1.Ventricular Assist Devices
14.5.5.1.1.1.Left Ventricular Assist Devices  

14.5.5.1.1.2.Percutaneous Ventricular Assist Devices

14.5.5.1.1.3.Biventricular Assist Devices

14.5.5.1.1.4.Right Ventricular Assist Devices

14.5.5.1.2.Intra-Aortic Balloon Pumps

14.5.5.1.3.Total Artificial Hearts

14.5.5.2.South Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
14.5.5.2.1.Implantable Heart Pump Devices

14.5.5.2.2.Extracorporeal Heart Pump Devices

14.5.5.3.South Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
14.5.5.3.1.Bridge-To-Transplant (BTT)

14.5.5.3.2.Bridge-To-Candidacy (BTC)

14.5.5.3.3.Destination Therapy (DT)

14.5.5.3.4.Other Therapies

14.5.6.Rest of Middle East & Africa
14.5.6.1.Rest of Middle East & Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
14.5.6.1.1.Ventricular Assist Devices
14.5.6.1.1.1.Left Ventricular Assist Devices  

14.5.6.1.1.2.Percutaneous Ventricular Assist Devices

14.5.6.1.1.3.Biventricular Assist Devices

14.5.6.1.1.4.Right Ventricular Assist Devices

14.5.6.1.2.Intra-Aortic Balloon Pumps

14.5.6.1.3.Total Artificial Hearts

14.5.6.2.Rest of Middle East & Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
14.5.6.2.1.Implantable Heart Pump Devices

14.5.6.2.2.Extracorporeal Heart Pump Devices

14.5.6.3.Rest of Middle East & Africa Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
14.5.6.3.1.Bridge-To-Transplant (BTT)

14.5.6.3.2.Bridge-To-Candidacy (BTC)

14.5.6.3.3.Destination Therapy (DT)

14.5.6.3.4.Other Therapies

14.6.Key Segment for Channeling Investments
14.6.1.By Country

14.6.2.By Product

14.6.3.By Type

14.6.4.By Therapy

15.Latin America Heart Pump Device Market Analysis and Forecasts, 2023 – 2031
15.1.Overview
15.1.1.Latin America Heart Pump Device Market Revenue (US$ Mn)

15.2.Latin America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
15.2.1.Ventricular Assist Devices
15.2.1.1.Left Ventricular Assist Devices  

15.2.1.2.Percutaneous Ventricular Assist Devices

15.2.1.3.Biventricular Assist Devices

15.2.1.4.Right Ventricular Assist Devices

15.2.2.Intra-Aortic Balloon Pumps

15.2.3.Total Artificial Hearts

15.3.Latin America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
15.3.1.Implantable Heart Pump Devices

15.3.2.Extracorporeal Heart Pump Devices

15.4.Latin America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
15.4.1.Bridge-To-Transplant (BTT)

15.4.2.Bridge-To-Candidacy (BTC)

15.4.3.Destination Therapy (DT)

15.4.4.Other Therapies

15.5.Latin America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Country
15.5.1.Brazil
15.5.1.1.Brazil Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
15.5.1.1.1.Ventricular Assist Devices
15.5.1.1.1.1.Left Ventricular Assist Devices  

15.5.1.1.1.2.Percutaneous Ventricular Assist Devices

15.5.1.1.1.3.Biventricular Assist Devices

15.5.1.1.1.4.Right Ventricular Assist Devices

15.5.1.1.2.Intra-Aortic Balloon Pumps

15.5.1.1.3.Total Artificial Hearts

15.5.1.2.Brazil Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
15.5.1.2.1.Implantable Heart Pump Devices

15.5.1.2.2.Extracorporeal Heart Pump Devices

15.5.1.3.Brazil Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
15.5.1.3.1.Bridge-To-Transplant (BTT)

15.5.1.3.2.Bridge-To-Candidacy (BTC)

15.5.1.3.3.Destination Therapy (DT)

15.5.1.3.4.Other Therapies

15.5.2.Argentina
15.5.2.1.Argentina Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
15.5.2.1.1.Ventricular Assist Devices
15.5.2.1.1.1.Left Ventricular Assist Devices  

15.5.2.1.1.2.Percutaneous Ventricular Assist Devices

15.5.2.1.1.3.Biventricular Assist Devices

15.5.2.1.1.4.Right Ventricular Assist Devices

15.5.2.1.2.Intra-Aortic Balloon Pumps

15.5.2.1.3.Total Artificial Hearts

15.5.2.2.Argentina Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
15.5.2.2.1.Implantable Heart Pump Devices

15.5.2.2.2.Extracorporeal Heart Pump Devices

15.5.2.3.Argentina Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
15.5.2.3.1.Bridge-To-Transplant (BTT)

15.5.2.3.2.Bridge-To-Candidacy (BTC)

15.5.2.3.3.Destination Therapy (DT)

15.5.2.3.4.Other Therapies

15.5.3.Rest of Latin America
15.5.3.1.Rest of Latin America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Product
15.5.3.1.1.Ventricular Assist Devices
15.5.3.1.1.1.Left Ventricular Assist Devices  

15.5.3.1.1.2.Percutaneous Ventricular Assist Devices

15.5.3.1.1.3.Biventricular Assist Devices

15.5.3.1.1.4.Right Ventricular Assist Devices

15.5.3.1.2.Intra-Aortic Balloon Pumps

15.5.3.1.3.Total Artificial Hearts

15.5.3.2.Rest of Latin America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Type
15.5.3.2.1.Implantable Heart Pump Devices

15.5.3.2.2.Extracorporeal Heart Pump Devices

15.5.3.3.Rest of Latin America Heart Pump Device Market Revenue (US$ Mn) and Forecasts, By Therapy
15.5.3.3.1.Bridge-To-Transplant (BTT)

15.5.3.3.2.Bridge-To-Candidacy (BTC)

15.5.3.3.3.Destination Therapy (DT)

15.5.3.3.4.Other Therapies

15.6.Key Segment for Channeling Investments
15.6.1.By Country

15.6.2.By Product

15.6.3.By Type

15.6.4.By Therapy

16.Competitive Benchmarking
16.1.Market Share Analysis, 2022

16.2.Global Presence and Growth Strategies
16.2.1.Mergers and Acquisitions

16.2.2.Product Launches

16.2.3.Investments Trends

16.2.4.R&D Initiatives

17.Player Profiles
17.1.Abbott
17.1.1.Company Details

17.1.2.Company Overview

17.1.3.Product Offerings

17.1.4.Key Developments

17.1.5.Financial Analysis

17.1.6.SWOT Analysis

17.1.7.Business Strategies

17.2.ABIOMED
17.2.1.Company Details

17.2.2.Company Overview

17.2.3.Product Offerings

17.2.4.Key Developments

17.2.5.Financial Analysis

17.2.6.SWOT Analysis

17.2.7.Business Strategies

17.3.Berlin Heart
17.3.1.Company Details

17.3.2.Company Overview

17.3.3.Product Offerings

17.3.4.Key Developments

17.3.5.Financial Analysis

17.3.6.SWOT Analysis

17.3.7.Business Strategies

17.4.Fresenius Medical Care AG & Co. KGaA
17.4.1.Company Details

17.4.2.Company Overview

17.4.3.Product Offerings

17.4.4.Key Developments

17.4.5.Financial Analysis

17.4.6.SWOT Analysis

17.4.7.Business Strategies

17.5.Getinge
17.5.1.Company Details

17.5.2.Company Overview

17.5.3.Product Offerings

17.5.4.Key Developments

17.5.5.Financial Analysis

17.5.6.SWOT Analysis

17.5.7.Business Strategies

17.6.Jarvik Heart, Inc.
17.6.1.Company Details

17.6.2.Company Overview

17.6.3.Product Offerings

17.6.4.Key Developments

17.6.5.Financial Analysis

17.6.6.SWOT Analysis

17.6.7.Business Strategies

17.7.LivaNova, Inc.
17.7.1.Company Details

17.7.2.Company Overview

17.7.3.Product Offerings

17.7.4.Key Developments

17.7.5.Financial Analysis

17.7.6.SWOT Analysis

17.7.7.Business Strategies

17.8.Medtronic
17.8.1.Company Details

17.8.2.Company Overview

17.8.3.Product Offerings

17.8.4.Key Developments

17.8.5.Financial Analysis

17.8.6.SWOT Analysis

17.8.7.Business Strategies

17.9.SynCardia Systems, LLC
17.9.1.Company Details

17.9.2.Company Overview

17.9.3.Product Offerings

17.9.4.Key Developments

17.9.5.Financial Analysis

17.9.6.SWOT Analysis

17.9.7.Business Strategies

17.10.Teleflex Incorporated
17.10.1.Company Details

17.10.2.Company Overview

17.10.3.Product Offerings

17.10.4.Key Developments

17.10.5.Financial Analysis

17.10.6.SWOT Analysis

17.10.7.Business Strategies

17.11.Other Market Participants

18.Key Findings

.

**Exclusive for Multi-User and Enterprise User.

Global Heart Pump Device Market Segmentation

By Product

 Ventricular Assist Devices
 Left Ventricular Assist Devices

 Percutaneous Ventricular Assist Devices

 Biventricular Assist Devices

 Right Ventricular Assist Devices

 Intra-Aortic Balloon Pumps

 Total Artificial Hearts

By Type

 Implantable Heart Pump Devices

 Extracorporeal Heart Pump Devices

By Therapy

 Bridge-To-Transplant (BTT)

 Bridge-To-Candidacy (BTC)

 Destination Therapy (DT)

 Other Therapies

By Region

 North America (U.S., Canada, Mexico, Rest of North America)

 Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)

 Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)

 Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)

 Latin America (Brazil, Argentina, Rest of Latin America)

**Note: The report covers cross-segmentation analysis by region further into countries

.

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Global Heart Pump Device Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top